NYSCF Press Releases
NYSCF scientists, in collaboration with others, compared stem cells created using two different methods: induced pluripotent stem (iPS) cells and stem cells created by somatic cell nuclear transfer (SCNT). The scientists compared the two methods using three different sources of cells, showing that the mutations seen in reprogrammed cells are likely…
NYSCF scientists, in collaboration with others, successfully created a human cell model of sporadic Parkinson's disease in a dish. The scientists had the unique opportunity to study contributing factors to Parkinson's disease through a set of identical twins, one of which has the disease.  The study, published as the cover story…
The NYSCF Research Institute, through the launch of its repository in 2015, will provide the largest-ever number of stem cell lines available to the scientific research community. Initially, over 600 induced pluripotent stem (iPS) cell lines and 1,000 cultured fibroblasts from over 1,000 unique human subjects will be made available,…
The 2014 NYSCF - Robertson Investigators were announced at NYSCF’s Ninth Annual Gala and Science Fair, held at Jazz at Lincoln Center in Manhattan. Each Investigator will receive a $1.5 million award, which will be disbursed over the next five years, which will enable them to expand their laboratories and train…
NYSCF announced that Dr. Marius Wernig, of Stanford University, is the recipient of the NYSCF - Robertson Stem Cell Prize. Dr. Wernig and his team discovered that human skin cells can be converted directly into functional neurons, termed induced neuronal (iN) cells, in a period of four to five weeks with the…
For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they developed an accelerated protocol to induce these stem cells into becoming oligodendrocytes, the myelin-forming cells of the central nervous system implicated in multiple sclerosis…
NYSCF and Beyond Batten Disease Foundation (BBDF) are partnering to develop stem cell resources to investigate and explore new treatments and, ultimately, find a cure for juvenile Batten disease, a fatal illness affecting children. NYSCF scientists will create induced pluripotent stem (iPS) cell lines from skin samples of young people affected…
Recognizing the enormous research potential of shared iPS cell lines, the NYSCF Research Institute and eagle-i Network are partnering to make NYSCF iPS cell lines and related information available to the public on a user-friendly, web-based, searchable database. The database (called the Induced Pluripotent Stem Cell database) will help scientists find…
A team of scientists led by the NYSCF Research Institute's Dr. Dieter Egli report the first ever patient-specific, diploid (i.e. with two sets of chromosomes, the normal number in human cells) embryonic stem cell line created from an adult with type 1 diabetes using somatic cell nuclear transfer (SCNT). Furthermore,…
Dr. Mahendra Rao joins The New York Stem Cell Foundation Research Institute as the Vice President for Regenerative Medicine. Dr. Rao brings decades of experience in stem cell science and business development to NYSCF's mission to translate stem cell research into cures.  Dr. Rao, who holds an MD degree and…
Page 1 of 9

NYSCF Cell Images

You are here: News Press Releases